NCT02900313View on ClinicalTrials.gov

Serum Phosphatemia Predictive Marker for AKI Diagnosis After Cardiac Surgery

NACompletedINTERVENTIONAL
Enrollment

264

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

April 30, 2016

Study Completion Date

July 31, 2016

Conditions
Cardiac Surgery With Cardiopulmonary BypassComplete Serum Phosphorus MeasureComplete Serum Creatinine Measure
Interventions
OTHER

cardiac surgery

Cohort of patients who are more than 18 years having cardiac surgery and having benefited from a dosage of serum phosphorus level and serum creatinine during all the duration of the hospitalisation

Trial Locations (1)

34295

Hôpital Arnaud de Villeneuve, Montpellier

All Listed Sponsors
lead

University Hospital, Montpellier

OTHER

NCT02900313 - Serum Phosphatemia Predictive Marker for AKI Diagnosis After Cardiac Surgery | Biotech Hunter | Biotech Hunter